(Q33338630)

25 July 2017

1 reference

18 December 2019

1 reference

title

Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer (English)

1 reference

25 July 2017

1 reference

18 December 2019

1 reference

7 August 2019

1 reference

18 December 2019

1 reference

1 reference

3

Paul D P Pharoah

1 reference

25 July 2017

4

Carlos Caldas

1 reference

25 July 2017

1

Grace M Callagy

1 reference

25 July 2017

Mark J Webber

2

1 reference

25 July 2017

language of work or name

English

0 references

publication date

29 May 2008

9 references

25 July 2017

13 March 2019

3 April 2019

19 June 2019

17 June 2019

2 August 2019

7 August 2019

20 November 2019

18 December 2019

9 references

25 July 2017

13 March 2019

3 April 2019

19 June 2019

17 June 2019

2 August 2019

7 August 2019

20 November 2019

18 December 2019

8

1 reference

25 July 2017

page(s)

153

1 reference

Creative Commons Attribution 2.0 Generic

25 July 2017

copyright license

8 references

13 March 2019

3 April 2019

19 June 2019

17 June 2019

2 August 2019

7 August 2019

20 November 2019

on focus list of Wikimedia project

18 December 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

A consensus prognostic gene expression classifier for ER positive breast cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Genome-wide analysis of estrogen receptor binding sites

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

A gene-expression signature to predict survival in breast cancer across independent data sets.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

BCL2 family in DNA damage and cell cycle control

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

"Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

A prognostic index for operable, node-negative breast cancer.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Measuring inconsistency in meta-analyses

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference?

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Molecular classification of breast carcinomas using tissue microarrays

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Gene expression profiling predicts clinical outcome of breast cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Molecular portraits of human breast tumours

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Clinical studies of Bcl-2 and treatment benefit in breast cancer patients.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Bias in meta-analysis detected by a simple, graphical test

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Prognostic value of bcl-2 expression in invasive breast cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Meta-analysis in clinical trials

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.

14 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-153

Reporting recommendations for tumor marker prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-153

Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-153

Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-153

Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-153

bcl-2 automated and quantitative immunocytochemical assays in breast carcinomas: correlation with 10-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-153

Significance of p53, Bcl-2, and HER-2/neu protein expression in Omani Arab females with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-153

Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-153

The use of a prognostic table to aid decision making on adjuvant therapy for women with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-153

Potential predictive value of Bcl-2 for response to tamoxifen in the adjuvant setting of node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-153

Cell-cycle-associated markers and clinical outcome in human epithelial cancers: a tissue microarray study.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Prognostic value of apoptosis in breast cancer (pT1-pT2). A TUNEL, p53, bcl-2, bag-1 and Bax immunohistochemical study

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Prognostic value of Bcl-2 in invasive breast cancer receiving chemotherapy and endocrine therapy

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

Bcl-2 immunostaining: a way to finding unresponsive postmenopausal N+ breast cancer patients.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

bcl-2 and apoptosis in lymph node positive breast carcinoma.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430210

31 October 2018

The molecular outlook

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-153

Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-153

c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patients

21 January 2018

1 reference

12 December 2020

TAILORx: trial assigning individualized options for treatment (Rx)

1 reference

12 December 2020

Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis

1 reference

12 December 2020

Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy

1 reference

12 December 2020

Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990–1999

1 reference

12 December 2020

Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index

1 reference

12 December 2020

The Nottingham prognostic index in primary breast cancer

1 reference

12 December 2020

Paradoxical inhibition of solid tumor cell growth by bcl2

1 reference

12 December 2020

Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis

1 reference

12 December 2020

p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients

1 reference

12 December 2020

bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study

1 reference

12 December 2020

Prognostic significance of apoptosis related proteins Bcl-2 and Bax in node-negative breast cancer patients

1 reference

12 December 2020

Prognostic indicators for breast cancer patients with one to three regional lymph node metastases, with special reference to alterations in expression levels of bcl-2, p53 and c-erbB-2 proteins

1 reference

12 December 2020

Bax immunohistochemical expression in breast carcinoma: a study with long term follow-up

1 reference

12 December 2020

Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-8-153

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference

25 July 2017

1 reference